A trial in India to test a new path for curing Alzheimer s thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Titled "Impact of Glutathione (GSH) Supplementation in Mild Cognitive Impairment (MCI) Patients: A Randomized Control Trial", the study is funded by the Department of Biotechnology (DBT), approved by the Drugs Controller General of India and is listed on Clinical Trials Registry-India (CTRI).
Donanemab may have slightly higher adverse events than other drugs and patients need to be gene-tested to prevent them. The therapy also does not cure, meaning the benefits will last for a limited time. A cost-benefit analysis is required for use but at least drug development for a condition that did not have any is welcome, say neurologists
Health Specials indianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianexpress.com Daily Mail and Mail on Sunday newspapers.